Risk factors and renal outcomes of AKI in children with secondary steroid-resistant nephrotic syndrome

被引:2
作者
Yu, Nannan [1 ]
Ouyang, Xiaojun [1 ]
Li, Jie [1 ]
Gao, Jie [1 ]
Zeng, Shuhan [1 ]
Zhuang, Hongjie [1 ]
Jiang, Mengjie [1 ]
Pei, Yuxin [1 ]
Jiang, Xiaoyun [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pediat Nephrol & Rheumatol, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Secondary steroid-resistant nephrotic syndrome; acute kidney injury; children; risk factors; outcome; ACUTE KIDNEY INJURY; CHILDHOOD; RECOVERY;
D O I
10.1080/0886022X.2024.2314637
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Acute kidney injury (AKI) is increasingly prevalent in children with nephrotic syndrome (NS). It is associated with adverse outcomes in NS, especially steroid-resistant nephrotic syndrome (SRNS). The incidence, risk factors and outcomes of AKI in secondary SRNS remain undefined. The main objectives of this study were to determine the risk factors and prognosis of AKI in hospitalized children with secondary SRNS. Material and methods: This retrospective study was conducted from January 2014 to December 2019, involving 172 hospitalizations with secondary SRNS admitted to the First Affiliated Hospital of Sun Yat-sen University. AKI was defined and classified in accordance with the 2012 Kidney Disease Improving Global Outcomes (KDIGO) guidelines. Results: AKI was found in 67 (39.0%) of 172 hospitalizations with secondary SRNS. Average age of onset in our group is 4.4 (3.1, 6.7) years with AKI and 3.7 (1.8, 5.6) years without AKI. Urea nitrogen level is 5.9 (4.1, 10.0) mmol/L with AKI and 5.1 (3.7, 7.0) mmol/L. Uric acid level is 446.0 (340.0, 567.0) umol/L with AKI and 401.0 (303.0, 496.0) umol/L. 24-h urinary protein level is 4.14 (2.9, 6.5) g with AKI and 2.5 (1.3, 5.3) without AKI. Multivariate logistic regression revealed that infection (OR = 5.287; 95% confidence interval, 2.349 to 11.899; p < 0.001), age at onset (OR = 1.180; 95% confidence interval, 1.032 to 1.349; p = 0.015) and uric acid level (OR = 1.003; 95% confidence interval, 1.000 to 1.006; p = 0.031) were significantly associated with the development of AKI in children with secondary SRNS. Among 72 children with secondary SRNS, six went to end-stage kidney disease (ESKD). Children in the AKI group were more likely to progress to ESKD compared with children in the non-AKI group (p = 0.017) with a median follow-up of 48.5months. Conclusion: AKI occurred in 39.0% of total hospitalizations associated with secondary SRNS. Risk factors including infection, age of onset, and uric acid level are associated with AKI in children with secondary SRNS. Furthermore, AKI was identified as a risk factor for the progression of secondary SRNS to ESKD.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Spectrum of mutations in Chinese children with steroid-resistant nephrotic syndrome
    Fang Wang
    Yanqin Zhang
    Jianhua Mao
    Zihua Yu
    Zhuwen Yi
    Li Yu
    Jun Sun
    Xiuxiu Wei
    Fangrui Ding
    Hongwen Zhang
    Huijie Xiao
    Yong Yao
    Weizhen Tan
    Svjetlana Lovric
    Jie Ding
    Friedhelm Hildebrandt
    Pediatric Nephrology, 2017, 32 : 1181 - 1192
  • [22] Mycophenolate mofetil therapy for children with steroid-resistant nephrotic syndrome
    Zhihui Li
    Cuirong Duan
    Jinhua He
    Tianhui Wu
    Mai Xun
    Yi Zhang
    Yan Yin
    Pediatric Nephrology, 2010, 25 : 883 - 888
  • [23] Spectrum of mutations in Chinese children with steroid-resistant nephrotic syndrome
    Wang, Fang
    Zhang, Yanqin
    Mao, Jianhua
    Yu, Zihua
    Yi, Zhuwen
    Yu, Li
    Sun, Jun
    Wei, Xiuxiu
    Ding, Fangrui
    Zhang, Hongwen
    Xiao, Huijie
    Yao, Yong
    Tan, Weizhen
    Lovric, Svjetlana
    Ding, Jie
    Hildebrandt, Friedhelm
    PEDIATRIC NEPHROLOGY, 2017, 32 (07) : 1181 - 1192
  • [24] Genetic screening in adolescents with steroid-resistant nephrotic syndrome
    Lipska-Zietkiewicz, Beata S.
    Iatropoulos, Paraskevas
    Maranta, Ramona
    Caridi, Gianluca
    Ozaltin, Fatih
    Anarat, Ali
    Balat, Ayse
    Gellermann, Jutta
    Trautmann, Agnes
    Erdogan, Ozlem
    Saeed, Bassam
    Emre, Sevinc
    Bogdanovic, Radovan
    Azocar, Marta
    Balasz-Chmielewska, Irena
    Benetti, Elisa
    Caliskan, Salim
    Mir, Sevgi
    Melk, Anette
    Ertan, Pelin
    Baskin, Esra
    Jardim, Helena
    Davitaia, Tinatin
    Wasilewska, Anna
    Drozdz, Dorota
    Szczepanska, Maria
    Jankauskiene, Augustina
    Serna Higuita, Lina Maria
    Ardissino, Gianluigi
    Ozkaya, Ozan
    Kuzma-Mroczkowska, Elzbieta
    Soylemezoglu, Oguz
    Ranchin, Bruno
    Medynska, Anna
    Tkaczyk, Marcin
    Peco-Antic, Amira
    Akil, Ipek
    Jarmolinski, Tomasz
    Firszt-Adamczyk, Agnieszka
    Dusek, Jiri
    Simonetti, Giacomo D.
    Gok, Faysal
    Gheissari, Alaleh
    Emma, Francesco
    Krmar, Rafael T.
    Fischbach, Michel
    Printza, Nikoleta
    Simkova, Eva
    Mele, Caterina
    Ghiggeri, Gian Marco
    KIDNEY INTERNATIONAL, 2013, 84 (01) : 206 - 213
  • [25] Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children
    Kang, Zhijuan
    Li, Zhihui
    Duan, Cuirong
    Wu, Tianhui
    Xun, Mai
    Ding, Yunfeng
    Zhang, Yi
    Zhang, Liang
    Yin, Yan
    PEDIATRIC NEPHROLOGY, 2015, 30 (07) : 1121 - 1129
  • [26] Treatment of steroid-resistant idiopathic nephrotic syndrome
    Chemli, J.
    Harbi, A.
    ARCHIVES DE PEDIATRIE, 2009, 16 (03): : 260 - 268
  • [27] Gene Mutations and Steroid-Resistant Nephrotic Syndrome
    Mahdavi-Mazdeh, Mitra
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2013, 7 (05) : 335 - 336
  • [28] IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome
    Agnes Trautmann
    Marina Vivarelli
    Susan Samuel
    Debbie Gipson
    Aditi Sinha
    Franz Schaefer
    Ng Kar Hui
    Olivia Boyer
    Moin A Saleem
    Luciana Feltran
    Janina Müller-Deile
    Jan Ulrich Becker
    Francisco Cano
    Hong Xu
    Yam Ngo Lim
    William Smoyer
    Ifeoma Anochie
    Koichi Nakanishi
    Elisabeth Hodson
    Dieter Haffner
    Pediatric Nephrology, 2020, 35 : 1529 - 1561
  • [29] New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome
    van Husen, Michael
    Kemper, Markus J.
    PEDIATRIC NEPHROLOGY, 2011, 26 (06) : 881 - 892
  • [30] Cyclosporine A and steroid therapy in childhood steroid-resistant nephrotic syndrome
    Tahar, Gargah
    Rachid, Lakhoua M.
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2010, 3 : 117 - 121